Article
Resusceptibility to Ceftazidime-Avibactam in Tigecycline-Exposed NDM-Producing CRECC
2026-03-11
Abstract excerpt
<title>Abstract</title> <p> Purpose Carbapenem-resistant <italic>Enterobacter cloacae</italic> complex (CRECC) has become an increasingly important pathogen in healthcare-associated infections, with limited treatment options and a high mortality rate. As reports of antimicrobial resistance continue to rise, tigecycline (TGC) and ceftazidime-avibactam (CZA) have emerged as the last-line therapies for CRECC inf...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f375a752-ef90-53a3-9e30-0881f2801050
- DOI
- 10.21203/rs.3.rs-8784943/v1
